QuidelOrtho (QDEL)
NASDAQHealth CareMedical - SpecialtiesSnapshot 2026-09-04
$13.97+0.29%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - SpecialtiesSnapshot 2026-09-04
QuarterlyIQ Insights · QDEL
Next print, the company's guidance track record, and the earnings events we've seen in the last few years.
Likelihood the company beats analyst consensus on its next print. Read from its own beat history plus how sector peers have been reporting. Not a price-direction call: a serial beater often has the beat already priced in.
Prints it beat consensus, recent quarters.
Indicative, not a guarantee. Base rate ~71%.
Industry peers that beat since this name last reported.
Management's most recent EPS guidance action.
expected = 0.35*own_median(25.0) + peer(0.2*2.0) + term(-3.0) → 6.14% (capped ±15.0)
Calibrated likelihood the company misses analyst consensus on its next print, read from its own miss history plus its industry base rate. A fundamental tilt, not a price call — and a quiet watch-flag, not an alarm.
Worth watching into the next print: this name has erratic recent earnings surprises and missed its most recent quarter. A fundamental tilt, not a price call.
Calibrated. Base rate ~24%.
Consecutive quarters it missed, most recent run.
How often this industry misses, baseline.
Industry peers that missed in the recent window.
Average absolute move on past earnings days.
Annualized: recent baseline volatility.
Of the last 0 guided quarters.
Actual vs. guided EPS, signed.
Excess return vs. sector ETF, day after print.
Earnings prints and pre-announcements detected in the SEC filing stream.
Results of Operations and Financial Condition. On August 6, 2026, QuidelOrtho Corporation (“QuidelOrtho”) issued a press release announcing the financial results for its second quarter ended June 28, 2026 and will hold an earnings conference call at 2:00 p.m., Pacific Time, on August 6, 2026 to discuss such results. A copy of the press release is furnished with this Current Report on Form 8-K (“Form 8-K”) as Exhibit 99.1. The information in this Form 8-K, including Exhibit 99.1, is being furn…
Quarterly EPS and revenue actuals vs. consensus across the last eight quarters (including beat/miss size and the forward consensus heading into the next print) are on the way.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Results of Operations and Financial Condition. On May 5, 2026, QuidelOrtho Corporation (“QuidelOrtho”) issued a press release announcing the financial results for its first quarter ended March 29, 2026 and will hold an earnings conference call at 2:00 p.m., Pacific Time, on May 5, 2026 to discuss such results. A copy of the press release is furnished with this Current Report on Form 8-K (“Form 8-K”) as Exhibit 99.1. The information in this Form 8-K, including Exhibit 99.1, is being furnished…
Results of Operations and Financial Condition. On April 15, 2026, QuidelOrtho Corporation (“QuidelOrtho”) issued a press release announcing its preliminary unaudited revenue for its first quarter of 2026, ended March 29, 2026. A copy of the press release is furnished with this Current Report on Form 8-K (“Form 8-K”) as Exhibit 99.1. The information in this Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange…
Results of Operations and Financial Condition. On February 11, 2026, QuidelOrtho Corporation (“QuidelOrtho”) issued a press release announcing the financial results for its fourth quarter and full year ended December 28, 2025 and will hold an earnings conference call at 2:00 p.m., Pacific Time, on February 11, 2026 to discuss such results. A copy of the press release is furnished with this Current Report on Form 8-K (“Form 8-K”) as Exhibit 99.1. The information in this Form 8-K, including Exh…
Results of Operations and Financial Condition. On November 5, 2025, QuidelOrtho Corporation (“QuidelOrtho”) issued a press release announcing the financial results for its third quarter ended September 28, 2025 and will hold an earnings conference call at 2:00 p.m., Pacific Time, on November 5, 2025 to discuss such results. A copy of the press release is furnished with this Current Report on Form 8-K (“Form 8-K”) as Exhibit 99.1. The information in this Form 8-K, including Exhibit 99.1, is be…
Results of Operations and Financial Condition. On August 5, 2025, QuidelOrtho Corporation (“QuidelOrtho”) issued a press release announcing the financial results for its second quarter ended June 29, 2025 and will hold an earnings conference call at 2:00 p.m., Pacific Time, on August 5, 2025 to discuss such results. A copy of the press release is furnished with this Current Report on Form 8-K (“Form 8-K”) as Exhibit 99.1. The information in this Form 8-K, including Exhibit 99.1, is being furn…
Results of Operations and Financial Condition. On May 7, 2025, QuidelOrtho Corporation (“QuidelOrtho”) issued a press release announcing the financial results for its first quarter ended March 30, 2025 and will hold an earnings conference call at 2:00 p.m., Pacific Time, on May 7, 2025 to discuss such results. A copy of the press release is furnished with this Current Report on Form 8-K (“Form 8-K”) as Exhibit 99.1. The information in this Form 8-K, including Exhibit 99.1, is being furnished…
Results of Operations and Financial Condition. On February 12, 2025, QuidelOrtho Corporation (“QuidelOrtho”) issued a press release announcing the financial results for its fourth quarter and full year ended December 29, 2024 and will hold an earnings conference call at 2:00 p.m., Pacific Time, on February 12, 2025 to discuss such results. A copy of the press release is furnished with this Current Report on Form 8-K (“Form 8-K”) as Exhibit 99.1. The information in this Form 8-K, including Exh…
Results of Operations and Financial Condition. On January 13, 2025, QuidelOrtho Corporation (“QuidelOrtho”) issued a press release announcing its preliminary unaudited revenue results for its fourth quarter ended December 29, 2024. A copy of the press release is furnished with this Current Report on Form 8-K (“Form 8-K”) as Exhibit 99.1. The information in this Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exc…
Results of Operations and Financial Condition. On November 7, 2024, QuidelOrtho Corporation (“QuidelOrtho”) issued a press release announcing the financial results for its third quarter ended September 29, 2024 and will hold an earnings conference call at 2:00 p.m., Pacific Time, on November 7, 2024 to discuss such results. A copy of the press release is furnished with this Current Report on Form 8-K (“Form 8-K”) as Exhibit 99.1. The information in this Form 8-K, including Exhibit 99.1, is be…
Results of Operations and Financial Condition. On July 31, 2024, QuidelOrtho Corporation (“QuidelOrtho”) issued a press release announcing the financial results for its second quarter ended June 30, 2024 and will hold an earnings conference call at 2:00 p.m., Pacific Time, on July 31, 2024 to discuss such results. A copy of the press release is furnished with this Current Report on Form 8-K (“Form 8-K”) as Exhibit 99.1. The information in this Form 8-K, including Exhibit 99.1, is being furnis…
Results of Operations and Financial Condition. On May 8, 2024, QuidelOrtho Corporation (“QuidelOrtho”) issued a press release announcing the financial results for its first quarter ended March 31, 2024 and will hold an earnings conference call at 2:00 p.m., Pacific Time, on May 8, 2024 to discuss such results. A copy of the press release is furnished with this Current Report on Form 8-K (“Form 8-K”) as Exhibit 99.1. The information in this Form 8-K, including Exhibit 99.1, is being furnished…